M. M. Center, A. Jemal, J. Lortet-tieulent, E. Ward, J. Ferlay et al., International variation in prostate cancer incidence and mortality rates, Eur Urol, vol.61, issue.6, pp.1079-92, 2012.

A. V. D'amico, R. Whittington, S. B. Malkowicz, D. Schultz, K. Blank et al., Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, vol.280, issue.11, pp.969-74, 1998.

J. B. Eifler, Z. Feng, B. M. Lin, M. T. Partin, E. B. Humphreys et al., An updated prostate cancer staging nomogram (Partin tables) based on cases from, BJU Int, vol.111, issue.1, pp.22-31, 2006.

A. Briganti, A. Larcher, F. Abdollah, U. Capitanio, A. Gallina et al., Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores, Eur Urol, vol.61, issue.3, pp.480-487, 2012.

P. M. Pierorazio, P. W. Walsh, A. W. Partin, and J. I. Epstein, Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system, BJU Int, vol.111, pp.753-60, 2013.

H. Samaratunga, B. Delahunt, T. Gianduzzo, G. Coughlin, D. Duffy et al., The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer, Pathology, vol.47, issue.6, pp.515-524, 2015.

J. I. Epstein, M. J. Zelefsky, D. D. Sjoberg, J. B. Nelson, L. Egevad et al., A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score, Eur Urol, vol.69, issue.3, pp.428-463, 2016.

S. R. Leyh-bannurah, S. Gazdovich, L. Budäus, E. Zaffuto, P. Dell'oglio et al., Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients, Prostate, vol.77, issue.1, pp.105-113, 2017.

L. Brureau, E. Emeville, L. Multigner, and P. Blanchet, Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies), Prog Urol, vol.28, issue.8-9, pp.442-449, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863040

W. J. Catalona, D. S. Smith, T. L. Ratliff, K. M. Dodds, D. E. Coplen et al., Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, vol.324, pp.1156-61, 1991.

A. V. Sarma, S. Sauver, J. L. Jacobson, D. J. Mcgree, M. E. Klee et al., Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study, Urology, vol.83, issue.1, pp.88-93, 2014.

S. D. Ellis, B. Blackard, W. R. Carpenter, M. Mishel, R. C. Chen et al., Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina, Cancer, vol.119, issue.12, pp.2282-90, 2013.

M. S. Lucia, D. G. Bostwick, M. C. Somerville, I. L. Fowler, and R. S. Rittmaster, Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial, Arch Pathol Lab Med, vol.137, issue.12, pp.1740-1746, 2013.

J. Grogan, R. Gupta, K. L. Mahon, P. D. Stricker, A. M. Haynes et al., Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up, BJU Int, vol.120, issue.5, pp.651-658, 2017.

H. J. Lavery and M. J. Droller, Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?, J Urol, vol.188, issue.5, pp.1667-75, 2012.